Mycoplasma polysaccharide protects against complement

Microbiology (United Kingdom)

Volumn 158, Issue 7, 2012, Pages 1867-1873

  Bolland, Jeffrey R ^a,c   Simmons, Warren L ^b   Daubenspeck, James M ^b   Dybvig, Kevin ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; COMPLEMENT COMPONENT C3; UNCLASSIFIED DRUG; VARIABLE SURFACE ANTIGEN PROTEIN;

ARTICLE; BACTERIAL CELL; BIOFILM; MOUSE; MYCOPLASMA PULMONIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; SURVIVAL;

ANIMALS; BACTERIAL PROTEINS; COMPLEMENT SYSTEM PROTEINS; MEMBRANE PROTEINS; MICE; MICROBIAL VIABILITY; MYCOPLASMA PULMONIS; POLYSACCHARIDES, BACTERIAL;

MURINAE; MYCOPLASMA; MYCOPLASMA PULMONIS; MYCOPLASMATALES;

EID: 84863712645     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.058222-0     Document Type: Article

References (23)

1. Alitalo, A., Meri, T., Rämö, L., Jokiranta, T. S., Heikkilä, T., Seppälä, I. J. T., Oksi, J., Viljanen, M. & Meri, S. (2001). Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun 69, 3685-3691.
2. Bhugra, B., Voelker, L. L., Zou, N., Yu, H. & Dybvig, K. (1995). Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions. Mol Microbiol 18, 703-714.
3. Comstock, L. E. & Kasper, D. L. (2006). Bacterial glycans: key mediators of diverse host immune responses. Cell 126, 847-850.
4. Daubenspeck, J. M., Bolland, J. R., Luo, W., Simmons, W. L. & Dybvig, K. (2009). Identification of exopolysaccharide-deficient mutants of Mycoplasma pulmonis. Mol Microbiol 72, 1235-1245.
5. Denison, A. M., Clapper, B. & Dybvig, K. (2005). Avoidance of the host immune system through phase variation in Mycoplasma pulmonis. Infect Immun 73, 2033-2039.
6. Dybvig, K., Gasparich, G. E. & King, K. W. (1995). Artificial transformation of mollicutes via polyethylene glycol-and electroporation-mediated methods. In Molecular and Diagnostic Procedures in Mycoplasmology, pp. 179-184. Edited by S. Razin & J. G. Tully. Orlando, FL: Academic Press.
7. Dybvig, K., French, C. T. & Voelker, L. L. (2000). Construction and use of derivatives of transposon Tn4001 that function in Mycoplasma pulmonis and Mycoplasma arthritidis. J Bacteriol 182, 4343-4347.
8. French, C. T., Lao, P., Loraine, A. E., Matthews, B. T., Yu, H. & Dybvig, K. (2008). Large-scale transposon mutagenesis of Mycoplasma pulmonis. Mol Microbiol 69, 67-76.
9. Gumulak-Smith, J., Teachman, A., Tu, A.-H. T., Simecka, J. W., Lindsey, J. R. & Dybvig, K. (2001). Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats. Mol Microbiol 40, 1037-1044.
10. Keo, T., Collins, J., Kunwar, P., Blaser, M. J. & Iovine, N. M. (2011). Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials. Virulence 2, 30-40.
11. Lindsey, J. R., Baker, H. J., Overcash, R. G., Cassell, G. H. & Hunt, C. E. (1971). Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol 64, 675-708.
12. O'Riordan, K. & Lee, J. C. (2004). Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 17, 218-234.
13. Razin, S. (1999). Adherence of pathogenic mycoplasmas to host cells. Biosci Rep 19, 367-372.
14. Razin, S., Yogev, D. & Naot, Y. (1998). Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 62, 1094-1156.
15. Rother, K., Till, G. O. & Hansch, G. M. (1997). The Complement System. New York: Springer.
16. Shen, X., Gumulak, J., Yu, H., French, C. T., Zou, N. & Dybvig, K. (2000). Gene rearrangements in the vsa locus of Mycoplasma pulmonis. J Bacteriol 182, 2900-2908.
17. Simmons, W. L. & Dybvig, K. (2003). The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene. Infect Immun 71, 5733-5738.
18. Simmons, W. L. & Dybvig, K. (2007). Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin. Infect Immun 75, 3696-3699.
19. Simmons, W. L., Zuhua, C., Glass, J. I., Simecka, J. W., Cassell, G. H. & Watson, H. L. (1996). Sequence analysis of the chromosomal region around and within the V-1-encoding gene of Mycoplasma pulmonis: evidence for DNA inversion as a mechanism for V-1 variation. Infect Immun 64, 472-479.
20. Simmons, W. L., Denison, A. M. & Dybvig, K. (2004). Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis. Infect Immun 72, 6846-6851.
21. Simmons, W. L., Bolland, J. R., Daubenspeck, J. M. & Dybvig, K. (2007). A stochastic mechanism for biofilm formation by Mycoplasma pulmonis. J Bacteriol 189, 1905-1913.
22. Taylor-Robinson, D., Schorlemmer, H. U., Furr, P. M. & Allison, A. C. (1978). Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and in immunity to these organisms. Clin Exp Immunol 33, 486-494.
23. Yus, E., Maier, T., Michalodimitrakis, K., van Noort, V., Yamada, T., Chen, W. H., Wodke, J. A., Güell, M., Martínez, S. & other authors (2009). Impact of genome reduction on bacterial metabolism and its regulation. Science 326, 1263-1268.